WTF? I can see us starting a whole new trend in marketing around the world! Exxon--non-inferior to Shell! Allstate--non-inferior to State Farm! Burger King--non inferior to Wendy's! Coke--non-inferior to Pepsi! Oh well, guess I'll play the follow the moth game now.........
You're an idiot. That's how they phrase studies that weren't powered for comparison. If you actually sold in this disease state, you might know that. Go worry about your moth.
You're correct..........I think this will help us get preferred formulary status on most insurance plans.
The other product is used as an active control for assay sensitivity purposes. Not for comparison purposes.
This is actually pretty funny. Who uses Seroquel for schizophrenia?? Nobody. You are competing against Zyprexa dummy. That would be generic Zyprexa. You are done.
And that study was published months ago and was approved for use in the field already. Why do you people who aren't even selling this drug or know anything about it post about these things?
ooooh, so it was approved for use in the field already... ooooh, that changes everything, even the market dynamic around generic olanzapine....
oh that's right. I forgot. just because it was approved for use in the field means that the actual market event of generic zyprexa will have no impact. WTF?